GMP Manufacturing Capabilities
Source: Upperton Pharma Solutions
We provide a flexible and dynamic approach to GMP manufacturing. From first in human (FIH) through to phase 3 clinical supplies manufacturing at our MHRA Approved and Home Office Approved (I-IV) GMP facility, Trent Gateway.
We offer manufacturing and packaging of Investigational Medicinal Products (IMP) in dosage forms including oral solid dosage forms, bulk dry powders, dry powder inhalers, nasal suspensions and solutions; for both biological molecules and small molecules.
- 10 individual GMP manufacturing suites
- 6 high-potent processing rooms
- 3 non-contained processing rooms
- Commercial scale processing room.
Our manufacturing process trains are built on the world’s leading technology, from a Gerteis Mini-Pactor to the O’Hara Tablet Coater, a GEA Post Hoist Blender, to the Zanasi Capsule Filler, and the Futorque X to ProCepT and Niro spray dryers.
Routes of delivery
- Oral (solid, semi-solid and liquid forms)
- Inhaled (nasal and pulmonary)
- Parenteral (sterile fill/finish)
Dosage forms
- Bulk spray dried powders
- Capsules
- Tablets
- Dry Powder Delivery Devices (nasal and pulmonary)
- Liquid Delivery Devices (nasal and pulmonary)
Upperton Pharma Solutions
This website uses cookies to ensure you get the best experience on our website. Learn more